Purpose-built for physicians GLP-1 therapy may reduce suicidal ideation risk for adolescents with obesity Key takeaways: Adolescents with obesity were less likely to have suicidal ideation or a reported suicide attempt if they were prescribed a GLP-1
It is available in several licensed UK formulations principally gels (e.g., Testogel, Testavan, Tostran) and injectable preparations (e.g., Nebido, Sustanon) and works by binding to androgen receptors throughout the body, influencing muscle mass, bone density, red blood cell production, libido, and mood
Semaglutide and other GLP1R agonists have transformed the treatment landscape for obesity and type 2 diabetes, primarily through their appetite-suppressing and weight-reducing actions
Hair follicles are metabolically active and depend on amino acids, iron, zinc, B vitamins, and vitamin D to function properly